Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context

Nanoscale

Volumn 2, Issue 10, 2010, Pages 2230-2236

  De Angelis, F ^a,b   Pujia, A ^a   Falcone, C ^b   Iaccino, E ^b   Palmieri, C ^b   Liberale, C ^a,b   Mecarini, F ^a   Candeloro, P ^b   Luberto, L ^b   De Laurentiis, A ^b   Das, G ^a   Scala, G ^b   Di Fabrizio, E ^a,b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B CELLS; CELL LINES; CELL SURFACES; CHEMICAL REAGENTS; CONTROLLED RELEASE; IN-VIVO; MULTIPLE LOADING; NANO SCALE; NANO-POROUS; NANO-POROUS SILICON; NANOCARRIERS; NANOPOROUS NANOPARTICLES; PHAGE DISPLAY TECHNOLOGY; ROOM TEMPERATURE; SMART DRUG DELIVERY SYSTEMS; SUSTAINED RELEASE; TARGETED DRUG DELIVERY; THERAPEUTIC EFFECTS; WATERSOLUBLE;

BIODEGRADATION; CELL CULTURE; CELL MEMBRANES; NANOPARTICLES; PEPTIDES; SURFACE CHEMISTRY;

CONTROLLED DRUG DELIVERY;

ANTINEOPLASTIC AGENT; BIOMATERIAL; DRUG CARRIER; NANOMATERIAL; WATER;

ANIMAL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; CHEMICAL PHENOMENA; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SCREENING; FEMALE; METABOLISM; METHODOLOGY; MOUSE; NANOTECHNOLOGY; NEOPLASM; SOLUBILITY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICE; MICE, INBRED BALB C; NANOSTRUCTURES; NANOTECHNOLOGY; NEOPLASMS; SOLUBILITY; WATER;

EID: 77957924367     PISSN: 20403364     EISSN: 20403372     Source Type: Journal    
DOI: 10.1039/c0nr00161a     Document Type: Article

References (30)

1. J. D. Byrne T. Betancourt L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Delivery Rev. 2008 60 1615 1626
2. R. Weissleder K. Kimberly E. Yi Sun T. Shtatland L. Josephson Cell-specific targeting of nanoparticles by multivalent attachment of small molecules Nat. Biotechnol. 2005 23 1418 1423
3. S. M. Okarvi Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer Cancer Treat. Rev. 2008 34 13 26
4. C. Palmieri et al., In vivo targeting and growth inhibition of the A20 murine B-cell lymphoma by an idiotype-specific peptide binder Blood 2010 116 226 10.1182/blood-2009-11-253617
5. D. Peer J. M. Karp S. Hong O. C. Farokhzad R. Margalit R. Langer Nanocarrier as an emerging platform for cancer therapy Nat. Nanotechnol. 2007 2 751 760
6. J. R. Heath M. E. Davis Nanotechnology and cancer Annu. Rev. Med. 2008 59 251 265
7. D. Putnam Drug delivery, The heart of the matter Nat. Mater. 2008 7 836 837
8. J. Salonen et al. Mesoporous silicon microparticles for oral drug delivery: Loading and release of five model drugs J. Controlled Release 2005 108 362 374
9. J. Salonen A. M. Kaukonen J. Hirvonen V. P. Lehto Mesoporous silicon in drug delivery applications J. Pharm. Sci. 2008 97 632 653
10. E. J. Anglin L. Cheng W. R. Freeman M. J. Sailor Porous silicon in drug delivery devices and materials Adv. Drug Delivery Rev. 2008 60 1266 1277
11. L. Vaccari et al. Porous silicon as drug carrier for controlled delivery of doxorubicin anticancer agent Microelectron. Eng. 2006 83 1598 1601
12. Ji-Ho Park L. Gu G. von Maltzahn E. Ruoslahti S. N. Bhatia M. J. Sailor Biodegradable luminescent silicon nanoparticles for in vivo application Nat. Mater. 2009 8 331 336
13. A. M. Tinsley-Bown et al. Tuning the pore size and surface chemistry of porous silicon for immunoassays Phys. Status Solidi A 2000 182 547
14. T. Limnell J. Riikonen J. Salonen A. M. Kaukonen L. Laitinen J. Hirvonen V. P. Letho Surface chemistry and pore size affect carrier properties of mesoporous silicon microparticles Int. J. Pharm. 2007 343 141 147
15. A. Verma O. Uzun Yuhua Hu Ying Hu Hee-Sun Han N. Watson S. Chen D. J. Irvine F. Stellacci Surface-structure-regulated-cell-membrane penetration by monolayer-protected nanoparticles Nat. Mater. 2008 7 588 595
16. D. F. Emerich C. G. Thanos The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis Biomol. Eng. 2006 23 171 184
17. J. Lovrić H. S. Bazzi Yan Cuie G. R. A. Fortin F. M. Winnik D. Maysinger Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots J. Mol. Med. 2005 83 377 385
18. A. L. De Cerio N. Zabalegui M. Rodriguez-Calvillo S. Inoges M. Bendandi Anti-idiotype antibodies in cancer treatment Oncogene 2007 26 3594 3602
19. S. H. C. Anderson H. Elliott D. J. Wallis L. T. Canham J. J. Powell Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions Phys. Status Solidi A 2003 197 331 335
20. R. Cortese et al. Identification of biologically active peptides using random libraries displayed on phage Curr. Opin. Biotechnol. 1995 6 73 80
21. M. Graner A. Raymond E. Akporiaye E. Katsanis Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines Cancer Immunol. Immunother. 2000 49 476 484
22. K. J. Kim C. Kanellopoulos-Langevin R. M. Merwin D. H. Sachs R. Asofsky Establishment and characterization of BALB/c lymphoma lines with B cell properties J Immunol 1979 122 549 554
23. M. F. Renschler R. R. Bhatt W. J. Dower R. Levy Synthetic peptide ligands of the antigen binding receptor induce programmed cell death in a human B-cell lymphoma Proc. Natl. Acad. Sci. U. S. A. 1994 91 3623 3627
24. M. F. Renschler H. G. Wada K. S. Fok R. Levy B-Lymphoma cells are activated by peptide ligands of the antigen binding receptor or by anti-idiotypic antibody to induce extracellular acidification Cancer Res 1995 55 5642 5647
25. O. H. Aina T. C. Sroka M. L. Chen K. S. Lam Therapeutic cancer targeting peptides Biopolymers 2002 66 184 199
26. O. H. Aina R. Liu J. L. Sutcliffe J. Marik Chong-Xian Pan K. S. Lam From combinatorial chemistry to cancer-targeting peptides Mol. Pharmaceutics 2007 4 631 651
27. J. K. Scott G. P. Smith Searching for peptide ligands with an epitope library Science 1990 249 386 390
28. G. Zhong G. P. Smith J. Berry R. C. Brunham Conformational mimicry of a chlamydial neutralization epitope on filamentous phage J Biol Chem 1994 269 24183 24188
29. G. T. Stevenson E. V. Elliott F. K. Stevenson Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target Fed Proc 1977 36 9 2268 71
30. R. Cortese F. Felici G. Galfre A. Luzzago P. Monaci A. Nicosia Epitope discovery using peptide libraries displayed on phage Trends Biotechnol. 1994 12 262 267